
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
View the Applied Clinical Trials June 2026 issue in an interactive format.
5 months ago
Getting Ahead in Trial Design





